Healthcare
Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.
Healthcare
A Lukewarm Listing Debut For BTS India-Backed Parabolic Drugs
BTS India Private Equity-backed pharmaceutical firm Parabolic Drugs has made a disappointing debut on the stock exchange. Although the scrip ......
Healthcare
Pharma Firms Demerging Domestic Biz; Eyeing Better Valuation
With multinational pharma companies scouring for deals to tap the Rs 41,000-crore Indian pharma market, domestic firms are actively exploring ......
Healthcare
Times Private Treaties Inks Pact With Novartis India
Times Private Treaties, the ad-for-equity investment arm of media house Bennett, Coleman & Company Ltd, has entered into a 'strategic ......
Healthcare
AstraZeneca India To De-list From Bourses
AstraZeneca Pharma India, Indian arm of Sweden-based AstraZeneca Pharmaceuticals AB, will de-list itself from domestic stock exchanges, BSE, NSE and ......
Healthcare
Alembic To De-merge Core Pharma Business
Alembic Limited has decided to de-merge its core pharmaceutical business into a 100% subsidiary company called Alembic Pharma Limited. As ......
Healthcare
ICICI Venture May Sell I-Ven Pharma To SPV Partner Dr Reddy's
ICICI Venture, India's largest private equity player, is looking at selling I-Ven Pharma Capital Limited, a Special Purpose Vehicle, to ......
Healthcare
GIC Singapore To Defer Rs 380Cr Infusion In Fortis
GIC Special Investments--the private equity arm of Singapore Government's GIC—has announced that it will defer its Rs 380-crore investment in ......
Healthcare
Warburg Pincus Invests $85 M in Metropolis Healthcare
Private equity major Warburg Pincus is investing $85 million (Rs 392 crore) in India's largest diagnostic laboratories chain Metropolis Healthcare ......
Healthcare
Piramal Healthcare To Buy Assets Of Canadian Firm BioSyntech
This is the second deal coming from the Piramal Healthcare quarters in weeks. Piramal Healthcare Ltd (PHL) has signed a ......
Healthcare
US Firm Amneal Pharma Buys Partner Stake In RAKS Pharma
The significance of India as a hub for low cost active pharmaceuticals ingredients (APIs) continues to make it attractive for ......
